Frazier Lifesciences Acquisition Corporation

NasdaqCM:FLAC Voorraadrapport

Marktkapitalisatie: US$183.7m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Frazier Lifesciences Acquisition Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Jamie Topper

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

Frazier Lifesciences SPAC said in talks to take NewAmsterdam Pharma public

Jul 19

CEO

Jamie Topper (60 yo)

no data

Tenure

Dr. James N. Topper, also known as Jamie, M. D., Ph. D., serves as Managing Partner at Frazier Life Sciences Management, LP. He serves as Managing Partner at Frazier Management, L. L.C.Dr. Topper was a Pa...